MHP
CTSO icon

Manatuck Hill Partners’s Cytosorbents Corp CTSO Stock Holding History

Manatuck Hill Partners’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-125,000
Closed -$966K – 81
2020
Q1 		$966K Buy
+125,000
New +$631K 0.89% 33
2019
Q1 		– Sell
-194,100
Closed -$1.57M – 97
2018
Q4 		$1.57M Sell
194,100
-109,200
-36% -$1.08M 0.81% 43
2018
Q3 		$3.91M Buy
303,300
+45,100
+17% +$565K 1.47% 25
2018
Q2 		$2.94M Buy
258,200
+12,000
+5% +$114K 1.18% 26
2018
Q1 		$1.74M Buy
246,200
+72,600
+42% +$549K 0.92% 30
2017
Q4 		$1.13M Buy
173,600
+23,600
+16% +$150K 0.59% 42
2017
Q3 		$930K Buy
+150,000
New +$764K 0.45% 46
2017
Q2 		– Sell
-155,000
Closed -$698K – 88
2017
Q1 		$698K Buy
155,000
+105,000
+210% +$587K 0.3% 60
2016
Q4 		$273K Buy
+50,000
New +$274K 0.13% 71

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Manatuck Hill Partners's CTSO Position: Q2 2020 in Review

Manatuck Hill Partners sold out of Cytosorbents Corp (CTSO) in Q2 2020, closing a stake of 125,000 shares — an estimated $966K sold.

Manatuck Hill Partners first reported a position in CTSO in Q4 2016 and held it in 9 quarters. The position peaked at $3.91M in Q3 2018. 91 funds tracked by Wall St. Rank hold CTSO as of Q2 2020.

  • Manatuck Hill Partners reported no remaining Cytosorbents Corp position as of Q2 2020 after selling out during the quarter.
  • Manatuck Hill Partners sold 125,000 Cytosorbents Corp shares in Q2 2020, an estimated $966K.
  • Manatuck Hill Partners first reported a position in Cytosorbents Corp in Q4 2016 and held it in 9 quarters.
  • Manatuck Hill Partners's Cytosorbents Corp position peaked at $3.91M in Q3 2018.
  • 91 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2020.

Based on Manatuck Hill Partners's 13F filing for Q2 2020, filed 14 Aug 2020.